$PLX
Protalix BioTherapeutics, Inc.

2016 Q3 Form 10-Q Financial Statement

#000114420416117287 Filed on August 08, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2016 Q2 2015 Q2
Revenue $4.670M $1.769M $1.336M
YoY Change 249.55% 32.41% -44.91%
Cost Of Revenue $4.248M $1.675M $225.0K
YoY Change 1804.93% 644.44% -85.98%
Gross Profit $422.0K $94.00K $1.111M
YoY Change -62.08% -91.54% 2.78%
Gross Profit Margin 9.04% 5.31% 83.16%
Selling, General & Admin $2.014M $2.206M $2.001M
YoY Change -6.89% 10.24% 27.78%
% of Gross Profit 477.25% 2346.81% 180.11%
Research & Development $6.353M $10.01M $6.023M
YoY Change 25.36% 66.25% -14.88%
% of Gross Profit 1505.45% 10652.13% 542.12%
Depreciation & Amortization $480.0K $490.0K $600.0K
YoY Change -18.64% -18.33% -25.0%
% of Gross Profit 113.74% 521.28% 54.01%
Operating Expenses $8.367M $12.22M $8.024M
YoY Change 15.71% 52.28% -7.15%
Operating Profit -$6.648M -$9.931M -$5.584M
YoY Change 32.91% 77.85% 2.52%
Interest Expense -$640.0K -$810.0K -$600.0K
YoY Change -36.63% 35.0% -10.45%
% of Operating Profit
Other Income/Expense, Net -$642.0K -$805.0K -$599.0K
YoY Change -36.62% 34.39% -10.86%
Pretax Income -$7.290M -$10.74M -$6.180M
YoY Change 21.1% 73.79% 0.98%
Income Tax
% Of Pretax Income
Net Earnings -$7.290M -$10.85M -$5.071M
YoY Change 90.84% 114.02% -17.13%
Net Earnings / Revenue -156.1% -613.51% -379.57%
Basic Earnings Per Share -$0.11
Diluted Earnings Per Share -$0.73 -$0.11 -$0.54
COMMON SHARES
Basic Shares Outstanding 99.81M shares 99.76M shares 93.60M shares
Diluted Shares Outstanding 99.76M shares

Balance Sheet

Concept 2016 Q3 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.30M $54.60M $43.20M
YoY Change 50.0% 26.39% -39.24%
Cash & Equivalents $51.32M $54.63M $43.24M
Short-Term Investments
Other Short-Term Assets $1.400M $5.500M $2.300M
YoY Change -48.45% 139.13% 15.0%
Inventory $4.900M $6.100M $6.368M
Prepaid Expenses
Receivables $2.096M $1.493M $1.900M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $59.60M $67.60M $53.90M
YoY Change 24.49% 25.42% -34.56%
LONG-TERM ASSETS
Property, Plant & Equipment $9.100M $9.500M $10.40M
YoY Change -8.61% -8.65% -16.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.700M $1.700M $1.700M
YoY Change 0.0% 0.0% -5.56%
Total Long-Term Assets $10.90M $11.30M $12.10M
YoY Change -6.16% -6.61% -15.31%
TOTAL ASSETS
Total Short-Term Assets $59.60M $67.60M $53.90M
Total Long-Term Assets $10.90M $11.30M $12.10M
Total Assets $70.50M $78.90M $66.00M
YoY Change 18.5% 19.55% -31.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.000M $3.800M $4.300M
YoY Change -2.44% -11.63% 19.44%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.30M $11.46M $25.50M
YoY Change -54.93% -55.06% -6.18%
LONG-TERM LIABILITIES
Long-Term Debt $72.40M $72.30M $67.70M
YoY Change 6.78% 6.79%
Other Long-Term Liabilities $2.800M $3.100M $37.90M
YoY Change -92.51% -91.82% -9.76%
Total Long-Term Liabilities $75.20M $75.38M $105.6M
YoY Change -28.48% -28.62% -3.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.30M $11.46M $25.50M
Total Long-Term Liabilities $75.20M $75.38M $105.6M
Total Liabilities $85.60M $86.84M $131.1M
YoY Change -33.13% -33.76% -3.91%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.10M -$7.976M -$65.14M
YoY Change
Total Liabilities & Shareholders Equity $70.50M $78.86M $66.00M
YoY Change 18.5% 19.49% -31.71%

Cashflow Statement

Concept 2016 Q3 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$7.290M -$10.85M -$5.071M
YoY Change 90.84% 114.02% -17.13%
Depreciation, Depletion And Amortization $480.0K $490.0K $600.0K
YoY Change -18.64% -18.33% -25.0%
Cash From Operating Activities -$3.440M -$11.69M -$5.350M
YoY Change -60.28% 118.5% -17.94%
INVESTING ACTIVITIES
Capital Expenditures $150.0K $330.0K $230.0K
YoY Change 15.38% 43.48% 109.09%
Acquisitions
YoY Change
Other Investing Activities $90.00K -$40.00K -$20.00K
YoY Change -325.0% 100.0% -75.0%
Cash From Investing Activities -$70.00K -$370.0K -$250.0K
YoY Change -58.82% 48.0% 25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 530.0K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.440M -11.69M -5.350M
Cash From Investing Activities -70.00K -370.0K -250.0K
Cash From Financing Activities 0.000 0.000 530.0K
Net Change In Cash -3.510M -12.06M -5.070M
YoY Change -60.25% 137.87% -24.55%
FREE CASH FLOW
Cash From Operating Activities -$3.440M -$11.69M -$5.350M
Capital Expenditures $150.0K $330.0K $230.0K
Free Cash Flow -$3.590M -$12.02M -$5.580M
YoY Change -59.16% 115.41% -15.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
75145000 USD
CY2016Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
75380000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
86380000 USD
CY2016Q2 us-gaap Liabilities
Liabilities
86840000 USD
us-gaap Revenues
Revenues
3028000 USD
us-gaap Revenues
Revenues
2448000 USD
us-gaap Cost Of Revenue
CostOfRevenue
507000 USD
us-gaap Cost Of Revenue
CostOfRevenue
2198000 USD
us-gaap Gross Profit
GrossProfit
2521000 USD
us-gaap Gross Profit
GrossProfit
250000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12123000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17347000 USD
plx Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
9666000 USD
plx Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
13844000 USD
plx Grants And Reimbursements Received Or Receivable
GrantsAndReimbursementsReceivedOrReceivable
2457000 USD
plx Grants And Reimbursements Received Or Receivable
GrantsAndReimbursementsReceivedOrReceivable
3503000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3823000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4201000 USD
CY2015Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
4301000 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11460000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97253000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78864000 USD
CY2015Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
1568000 USD
CY2016Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
293000 USD
CY2016Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
68017000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11235000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
-7976000 USD
CY2016Q2 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
2445000 USD
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
744000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
10873000 USD
CY2015Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
67796000 USD
CY2016Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
617000 USD
CY2015Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
2304000 USD
CY2016Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
4301000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10968000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17795000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1799000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1805000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
71000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
338000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1728000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1467000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11043000 USD
us-gaap Net Income Loss
NetIncomeLoss
-19451000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.2
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
93418666 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
99737348 shares
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-12696000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-19262000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1653000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-189000 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.14
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.2
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
CY2015Q2 us-gaap Revenues
Revenues
1336000 USD
CY2016Q2 us-gaap Revenues
Revenues
1769000 USD
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
225000 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
1675000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
1111000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
94000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6023000 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10013000 USD
CY2015Q2 plx Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
4694000 USD
CY2016Q2 plx Research Development And Engineering Expense Net
ResearchDevelopmentAndEngineeringExpenseNet
7819000 USD
CY2015Q2 plx Grants And Reimbursements Received Or Receivable
GrantsAndReimbursementsReceivedOrReceivable
1329000 USD
CY2016Q2 plx Grants And Reimbursements Received Or Receivable
GrantsAndReimbursementsReceivedOrReceivable
2194000 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2001000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2206000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5584000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9931000 USD
CY2015Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
642000 USD
CY2016Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
901000 USD
CY2015Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
43000 USD
CY2016Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
96000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-599000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-805000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-5071000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-10853000 USD
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
93635213 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
99758511 shares
CY2015Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6183000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10736000 USD
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1112000 USD
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-117000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.06
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
534000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.11
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.01
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
us-gaap Depreciation
Depreciation
1006000 USD
CY2015Q2 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
1814000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-65137000 USD
plx Share Based Compensation Restricted Stock Awards Net Of Forfeitures
ShareBasedCompensationRestrictedStockAwardsNetOfForfeitures
68000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-55601000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
595000 USD
plx Share Based Compensation Restricted Stock Awards Net Of Forfeitures
ShareBasedCompensationRestrictedStockAwardsNetOfForfeitures
378000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
973000 USD
us-gaap Depreciation
Depreciation
1223000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
55000 USD
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
-37000 USD
plx Gain Loss On Amounts Funded In Respect Of Employee Rights Upon Retirement
GainLossOnAmountsFundedInRespectOfEmployeeRightsUponRetirement
-23000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-335000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-640000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
332000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
51000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11529000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54767000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43238000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
602000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
167000 USD
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
107000 USD
plx Gain Loss On Amounts Funded In Respect Of Employee Rights Upon Retirement
GainLossOnAmountsFundedInRespectOfEmployeeRightsUponRetirement
3000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
300000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1273000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
575000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
84000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
228000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-21748000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-10521000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-21602000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1246000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
285000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11767000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21317000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-347000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-659000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4952000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
221000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
221000 USD
plx Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
656000 USD
plx Increase In Liabilities For Property Plant And Equipment
IncreaseInLiabilitiesForPropertyPlantAndEquipment
121000 USD
us-gaap Interest Paid Net
InterestPaidNet
1553000 USD
us-gaap Interest Paid Net
InterestPaidNet
1553000 USD
CY2015Q4 plx Payment Received Under License And Supply Agreement
PaymentReceivedUnderLicenseAndSupplyAgreement
36000000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19780594 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19617149 shares
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2027000 USD
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1180000 USD
CY2016Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3821000 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4587000 USD
CY2016Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
45900000 USD
CY2015Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
1993000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
324000 USD
CY2015Q4 us-gaap Disposal Group Including Discontinued Operation Inventory Current
DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
80000 USD
CY2016Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
293000 USD
CY2015Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1568000 USD
CY2015Q4 us-gaap Disposal Group Including Discontinued Operation Other Current Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
1568000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Other Current Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities
293000 USD
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
5146000 USD
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
209000 USD
us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
3932000 USD
us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
373000 USD
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
2753000 USD
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
-164000 USD
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
182000 USD
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
25000 USD
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
1653000 USD
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-189000 USD
plx Disposal Group Including Discontinued Operation Share In Collaboration Agreement
DisposalGroupIncludingDiscontinuedOperationShareInCollaborationAgreement
1539000 USD
plx Disposal Group Including Discontinued Operation Research And Development Expense
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
1110000 USD
plx Disposal Group Including Discontinued Operation Grants And Reimbursements Received Or Receivable
DisposalGroupIncludingDiscontinuedOperationGrantsAndReimbursementsReceivedOrReceivable
192000 USD
plx Disposal Group Including Discontinued Operation Research Development Expense Net
DisposalGroupIncludingDiscontinuedOperationResearchDevelopmentExpenseNet
918000 USD
CY2015Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
2446000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
167000 USD
CY2015Q2 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
1466000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
-167000 USD
CY2015Q2 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
91000 USD
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
-50000 USD
CY2015Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
1112000 USD
CY2016Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-117000 USD
CY2015Q2 plx Disposal Group Including Discontinued Operation Share In Collaboration Agreement
DisposalGroupIncludingDiscontinuedOperationShareInCollaborationAgreement
834000 USD
CY2015Q2 plx Disposal Group Including Discontinued Operation Research And Development Expense
DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopmentExpense
448000 USD
CY2015Q2 plx Disposal Group Including Discontinued Operation Grants And Reimbursements Received Or Receivable
DisposalGroupIncludingDiscontinuedOperationGrantsAndReimbursementsReceivedOrReceivable
185000 USD
CY2015Q2 plx Disposal Group Including Discontinued Operation Research Development Expense Net
DisposalGroupIncludingDiscontinuedOperationResearchDevelopmentExpenseNet
263000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1493000 USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
534000 USD
us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
2501 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-127000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
15000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
534000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
534000 USD
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20167947 shares
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19586488 shares
CY2016Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
219000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
Protalix BioTherapeutics, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001006281
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Trading Symbol
TradingSymbol
PLX
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
99808240 shares
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD

Files In Submission

Name View Source Status
0001144204-16-117287-index-headers.html Edgar Link pending
0001144204-16-117287-index.html Edgar Link pending
0001144204-16-117287.txt Edgar Link pending
0001144204-16-117287-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
plx-20160630.xml Edgar Link completed
plx-20160630.xsd Edgar Link pending
plx-20160630_cal.xml Edgar Link unprocessable
plx-20160630_def.xml Edgar Link unprocessable
plx-20160630_lab.xml Edgar Link unprocessable
plx-20160630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v445418_10q.htm Edgar Link pending
v445418_ex31-1.htm Edgar Link pending
v445418_ex31-2.htm Edgar Link pending
v445418_ex32-1.htm Edgar Link pending
v445418_ex32-2.htm Edgar Link pending